BioXcel Therapeutics, Inc. ($BTAI)
Filing Information
| Accession Number | 0001104659-26-065839 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
41,560
Total Value
$7,111.04
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer, Senior Vice President and Corporate Secretary | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 17,500 | โ | โ | 33,363 | Direct | โ | View Details | |
Chief Legal Officer, Senior Vice President and Corporate Secretary | Common Stock | โ | May 20, 2026 | Sale | 6,560 | $1.08 | $7,111.04 | 26,803 | Direct | โ | View Details | |
Chief Legal Officer, Senior Vice President and Corporate Secretary | Restricted Stock Units | Derivative | May 4, 2026 | Exercise/Conversion | 17,500 | $0.00 | $0.00 | 52,500 | Direct | โ | View Details |